EP Patent

EP2301934A1 — Nitrocatechol derivatives as COMT inhibitors

Assigned to Bial Portela and Cia SA · Expires 2011-03-30 · 15y expired

What this patent protects

New compounds of formula I are described: The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders.

USPTO Abstract

New compounds of formula I are described: The compounds have potentially valuable pharmaceutical properties in the treatment of some central and peripheral nervous system disorders.

Drugs covered by this patent

Patent Metadata

Patent number: EP2301934A1
Jurisdiction: EP
Classification: —
Expires: 2011-03-30
Drug substance claim: No
Drug product claim: No
Assignee: Bial Portela and Cia SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.